Investor Rights Law Firm Investigates Four Companies Amid Corporate Transactions
The law firm Halper Sadeh LLC has initiated investigations into Crinetics Pharmaceuticals, Twin Vee PowerCats, NextCure, and TriCo Bancshares. The firm is examining potential violations of federal securities laws and breaches of fiduciary duties to shareholders.
Investor rights law firm Halper Sadeh LLC is investigating four companies for potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders. The companies under scrutiny are Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), Twin Vee PowerCats Co. (NASDAQ: VEEE), NextCure, Inc. (NASDAQ: NXTC), and TriCo Bancshares (NASDAQ: TCBK).
Crinetics Pharmaceuticals has agreed to be acquired by Vertex Pharmaceuticals Incorporated for $85.00 per share in cash. Twin Vee PowerCats is involved in a merger with USFM Corporation. NextCure is set to merge with Avere Therapeutics, Inc., after which NextCure shareholders are expected to own approximately 1.21% of the combined entity. TriCo Bancshares is being sold to First Hawaiian, Inc., with TriCo shareholders anticipated to own about 35% of the combined company upon closing.
Halper Sadeh LLC stated that on behalf of shareholders, they may seek increased consideration, additional disclosures, or other relief. The firm emphasizes that it represents investors on a contingent fee basis, meaning clients are not responsible for out-of-pocket legal fees or expenses.
The law firm has a history of representing investors in securities fraud and corporate misconduct cases, contributing to corporate reforms and the recovery of millions of dollars for defrauded investors. They encourage shareholders of the mentioned companies to contact them to discuss their rights and options at no cost.